Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Nov 30, 2025 | Q3 2025Aug 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 66,647 | 28,862 | 28,267 | 39,420 | 26,665 |
| General And Administrative Expense | 66,647 | 28,862 | 28,267 | 39,420 | 26,665 |
| Other Operating Expenses | 87,123 | 56,615 | 27,403 | 81,659 | 193,815 |
| Operating Expense | 153,770 | 85,477 | 55,670 | 121,079 | 220,480 |
| Operating Income | -153,770 | -85,477 | -55,670 | -121,079 | -220,480 |
| EBIT | -153,770 | -85,477 | -55,670 | -121,079 | -220,480 |
| Interest Income | 160.00 | 160.00 | 271.00 | 234.00 | 271.00 |
| Interest Income Non Operating | 160.00 | 160.00 | 271.00 | 234.00 | 271.00 |
| Net Interest Income | -490.00 | -155.00 | 60.00 | 164.00 | -106.00 |
| Other Income Expense | -- | -- | -200,000 | -1,739 | -121,534 |
| Special Income Charges | -- | -- | -200,000 | -1,739 | -121,534 |
| Pretax Income | -154,260 | -85,632 | -255,610 | -120,915 | -220,586 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -154,260 | -85,632 | -255,610 | -120,915 | -220,586 |
| Net Income From Continuing Operation Net Minority Interest | -154,260 | -85,632 | -255,610 | -120,915 | -220,586 |
| Net Income Including Noncontrolling Interests | -154,260 | -85,632 | -255,610 | -120,915 | -220,586 |
| Net Income Common Stockholders | -154,260 | -85,632 | -255,610 | -120,915 | -220,586 |
| Net Income | -154,260 | -85,632 | -255,610 | -120,915 | -220,586 |
| EBITDA | -153,770 | -85,477 | -55,670 | -121,079 | -220,480 |
| Normalized EBITDA | -153,770 | -85,477 | 144,330 | -121,079 | -220,480 |
| Basic EPS | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |
| Diluted EPS | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |
| Basic Average Shares | 63.3M | 57.4M | 43.7M | 42.6M | 37.8M |
| Diluted Average Shares | 63.3M | 57.4M | 43.7M | 42.6M | 37.8M |
| Total Unusual Items | -- | -- | -200,000 | -1,739 | -121,534 |
| Total Unusual Items Excluding Goodwill | -- | -- | -200,000 | -1,739 | -121,534 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -154,260 | -85,632 | -55,610 | -120,915 | -220,586 |
| Diluted NI Availto Com Stockholders | -154,260 | -85,632 | -255,610 | -120,915 | -220,586 |
| Impairment Of Capital Assets | -- | -- | 200,000 | 1,739 | 121,534 |
| Net Income Continuous Operations | -154,260 | -85,632 | -255,610 | -120,915 | -220,586 |
| Net Non Operating Interest Income Expense | -490.00 | -155.00 | 60.00 | 164.00 | -106.00 |
| Other Gand A | 60,647 | 22,862 | 28,267 | 39,420 | 24,665 |
| Salaries And Wages | 6,000 | 6,000 | 0.00 | 0.00 | 2,000 |
| Total Expenses | 153,770 | 85,477 | 55,670 | 121,079 | 220,480 |
| Total Other Finance Cost | 650.00 | 315.00 | 211.00 | 70.00 | 377.00 |
| Line Item | Q4 2025Nov 30, 2025 | Q3 2025Aug 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 6.9M | 3.2M | 1.1M | 952,425 | 1.0M |
| Cash Cash Equivalents And Short Term Investments | 6.9M | 3.2M | 1.1M | 952,425 | 1.0M |
| Cash Financial | 6.9M | 3.2M | 1.1M | 952,425 | 1.0M |
| Accounts Receivable | 8,358 | 6,911 | 5,946 | 14,248 | 10,446 |
| Receivables | 8,358 | 6,911 | 5,946 | 14,248 | 58,446 |
| Prepaid Assets | 41,438 | 12,069 | 5,001 | 7,243 | 5,001 |
| Current Assets | 6.9M | 3.3M | 1.1M | 973,916 | 1.1M |
| Net PPE | 570,971 | 376,467 | 290,737 | 5,818 | 1.00 |
| Other Non Current Assets | 21,293 | 21,133 | 20,820 | 20,622 | 20,387 |
| Total Non Current Assets | 592,264 | 397,600 | 311,557 | 26,440 | 20,388 |
| Total Assets | 7.5M | 3.7M | 1.4M | 1.0M | 1.1M |
| Accounts Payable | 48,913 | 108,279 | 34,560 | 49,319 | 157,160 |
| Payables | 100,729 | 154,095 | 70,115 | 84,874 | 191,064 |
| Payables And Accrued Expenses | 100,729 | 154,095 | 70,115 | 84,874 | 191,064 |
| Current Liabilities | 150,529 | 203,895 | 124,115 | 138,874 | 245,064 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 150,529 | 203,895 | 124,115 | 138,874 | 245,064 |
| Common Stock | 43.7M | 39.6M | 36.9M | 36.2M | 36.1M |
| Capital Stock | 43.7M | 39.6M | 36.9M | 36.2M | 36.1M |
| Additional Paid In Capital | -- | -- | 2.0M | 2.0M | 2.0M |
| Retained Earnings | -38.4M | -38.2M | -37.6M | -37.4M | -37.2M |
| Gains Losses Not Affecting Retained Earnings | 2.0M | 2.0M | -- | -- | -- |
| Common Stock Equity | 7.4M | 3.5M | 1.3M | 861,482 | 880,397 |
| Stockholders Equity | 7.4M | 3.5M | 1.3M | 861,482 | 880,397 |
| Total Equity Gross Minority Interest | 7.4M | 3.5M | 1.3M | 861,482 | 880,397 |
| Total Capitalization | 7.4M | 3.5M | 1.3M | 861,482 | 880,397 |
| Net Tangible Assets | 7.4M | 3.5M | 1.3M | 861,482 | 880,397 |
| Tangible Book Value | 7.4M | 3.5M | 1.3M | 861,482 | 880,397 |
| Working Capital | 6.8M | 3.1M | 941,315 | 835,042 | 860,009 |
| Invested Capital | 7.4M | 3.5M | 1.3M | 861,482 | 880,397 |
| Share Issued | 66.7M | 57.7M | 47.0M | 42.9M | 42.4M |
| Ordinary Shares Number | 66.7M | 57.7M | 47.0M | 42.9M | 42.4M |
| Current Provisions | 49,800 | 49,800 | 54,000 | 54,000 | 54,000 |
| Dueto Related Parties Current | 51,816 | 45,816 | 35,555 | 35,555 | 33,904 |
| Other Receivables | -- | -- | -- | -- | 48,000 |
| Line Item | Q4 2025Nov 30, 2025 | Q3 2025Aug 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -198,432 | -70,492 | -59,825 | -233,148 | -265,684 |
| Cash Flow From Continuing Operating Activities | -198,432 | -70,492 | -59,825 | -233,148 | -265,684 |
| Stock Based Compensation | -- | -- | 0.00 | 0.00 | -- |
| Change In Working Capital | -44,172 | 15,140 | -4,215 | -112,233 | -45,098 |
| Changes In Account Receivables | -1,447 | 2,655 | 8,302 | -3,802 | -4,270 |
| Change In Receivables | -1,447 | 2,655 | 8,302 | -3,802 | -4,270 |
| Change In Payables And Accrued Expense | -53,367 | 6,499 | -14,759 | -106,189 | -35,828 |
| Change In Payable | -53,367 | 6,499 | -14,759 | -106,189 | -35,828 |
| Change In Other Working Capital | -- | -4,200 | -- | -- | -- |
| Capital Expenditure | -234,515 | -46,578 | -144,919 | -5,817 | -121,533 |
| Purchase Of PPE | -- | -- | -144,919 | -- | -121,533 |
| Net PPE Purchase And Sale | -234,515 | -46,578 | -144,919 | -5,817 | 0.00 |
| Investing Cash Flow | -234,675 | -46,737 | -145,117 | -6,052 | -271.00 |
| Cash Flow From Continuing Investing Activities | -234,675 | -46,737 | -145,117 | -6,052 | -271.00 |
| Issuance Of Capital Stock | 3.8M | 0.00 | 0.00 | 48,000 | 1.3M |
| Net Common Stock Issuance | 3.8M | 0.00 | 0.00 | 48,000 | 1.3M |
| Financing Cash Flow | 4.1M | 279,999 | 307,000 | 150,000 | 1.3M |
| Cash Flow From Continuing Financing Activities | 4.1M | 279,999 | 307,000 | 150,000 | 1.3M |
| Changes In Cash | 3.6M | 162,770 | 102,058 | -89,200 | 1.0M |
| Beginning Cash Position | 3.2M | 3.1M | 952,425 | 1.0M | 8,228 |
| End Cash Position | 6.9M | 3.2M | 1.1M | 952,425 | 1.0M |
| Free Cash Flow | -432,947 | -117,070 | -204,744 | -238,965 | -265,684 |
| Asset Impairment Charge | -- | -- | 200,000 | 1,739 | 121,534 |
| Change In Account Payable | -59,367 | 41,356 | -14,759 | -107,840 | 103,288 |
| Change In Prepaid Assets | 10,642 | 10,186 | 2,242 | -2,242 | -5,000 |
| Common Stock Issuance | 3.8M | 0.00 | 0.00 | 48,000 | 1.3M |
| Net Income From Continuing Operations | -154,260 | -85,632 | -255,610 | -120,915 | -220,586 |
| Net Other Investing Changes | -160.00 | -159.00 | -198.00 | -235.00 | -271.00 |
| Proceeds From Stock Option Exercised | 253,334 | 279,999 | 307,000 | 102,000 | 0.00 |